Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Up 13 % today in US .
View:
Post by Galaxym31 on Oct 09, 2023 1:14pm

Up 13 % today in US .

.
Comment by Rumpl3StiltSkin on Oct 09, 2023 2:54pm
Yes, and why?  What is up with the huge bid/ask??
Comment by BlueFranky on Oct 09, 2023 2:56pm
Would you mind posting the bid in the ask that you're talking about? Thank you
Comment by Oilminerdeluxe on Oct 09, 2023 3:01pm
Bid:  0,1676 x 1 010 000 Ask:  0,199 x 1 000 000 
Comment by PrettyPennies on Oct 09, 2023 3:06pm
Stock house is off by 2 decimal point again on the US. 
Comment by PrettyPennies on Oct 09, 2023 3:08pm
Try https://www.otcmarkets.com/stock/TLTFF/overview For US OTC level 2
Comment by Yajne on Oct 09, 2023 3:08pm
I've also seen massive US bid/asks for other stocks on the SH board. I think it is an error that they haven't yet corrected. Somebody posted on another board weeks ago that it's out by 1000X. Since then, I've always assumed the OTC bid/ask volumes are overblown. JMO
Comment by Pandora on Oct 09, 2023 3:20pm
I'm not that educated on reading this bid and ask stuff but my sense tells me that SH shows all digits i.e. 1,000,000 whereas TD shoes a truncated number such as 1,000 and drops off the last 3 digits as with the website that was posted. Is that what this discussion is about?
Comment by Pandora on Oct 09, 2023 3:27pm
Oops, got hasty in what I was saying. TD shows 100 and 101, so with 3 digits truncated that is 100,000 and 101,000 i.e. significantly different than 1,000,000 and 1,010,000 as shown on SH. My apologies.
Comment by Pandora on Oct 09, 2023 3:33pm
P.S. I notice that OTC website shows 10,000 and 10,100 but I have no idea if it is truncated or not. So we have 3 options, : 10,000(OTC) or 100,000(TD) or 1,000,000(SH) ?? I'll shut up now -- but will await the right number by someone who is smart on this stuff.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250